MedPath

Clinical efficacy of Liquid biopsy for acquired resistance to afatinib in EGFR positive NSCLC

Not Applicable
Conditions
EGFR mutation positive NSCLC
Registration Number
JPRN-UMIN000025112
Lead Sponsor
Aichi cancer center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Nothing

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath